GI-5 - Compound Card

GI-5

Select a section from the left sidebar

GI-5

Structure
Zoomed Structure
  • Family: Plantae - Oleaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Secoiridoid Glucoside
Canonical Smiles OC[C@H]1O[C@@H](O[C@@H]2OC=C([C@H](/C/2=C\C)CC(=O)OCCc2ccc(cc2)OC(=O)C[C@H]2/C(=C\C)/[C@@H](OC=C2C(=O)OC)O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)C(=O)OC)[C@@H]([C@H]([C@@H]1O)O)O
InChI InChI=1S/C42H54O22/c1-5-21-23(25(37(53)55-3)17-58-39(21)63-41-35(51)33(49)31(47)27(15-43)61-41)13-29(45)57-12-11-19-7-9-20(10-8-19)60-30(46)14-24-22(6-2)40(59-18-26(24)38(54)56-4)64-42-36(52)34(50)32(48)28(16-44)62-42/h5-10,17-18,23-24,27-28,31-36,39-44,47-52H,11-16H2,1-4H3/b21-5+,22-6+/t23-,24-,27+,28+,31+,32+,33-,34-,35+,36+,39-,40-,41-,42-/m0/s1
InChIKey ALDOLERJIYTYDY-CLEQCBGDSA-N
Formula C42H54O22
HBA 22
HBD 8
MW 910.87
Rotatable Bonds 16
TPSA 322.42
LogP -1.96
Number Rings 5
Number Aromatic Rings 1
Heavy Atom Count 64
Formal Charge 0
Fraction CSP3 0.57
Exact Mass 910.31
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Fraxinus excelsior Oleaceae Plantae 38873
2 Fraxinus excelsior Oleaceae Plantae 38873

Showing of synonyms

  • Ibarra A, Bai N, et al. (2011). Fraxinus excelsior seed extract FraxiPureTM limits weight gains and hyperglycemia in high-fat diet-induced obese mice. Phytomedicine,2011,18(6),479-485. [View]
  • Bai N, He K, et al. (2010). Iridoids from Fraxinus excelsior with adipocyte differentiation-inhibitory and PPARalpha activation activity. Journal of Natural Products,2010,73(1),2-6. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: O1CCCCC1OC2OC=CC(C2=C)CC(=O)OCCc3ccc(cc3)OC(=O)CC(C4=C)C=COC4OC5CCCCO5

Level: 4

Mol. Weight: 910.87 g/mol

Structure

SMILES: O1CCCCC1OC2OC=CC(C2=C)CC(=O)OCCc3ccc(cc3)OC(=O)CC(C4=C)C=COC4

Level: 3

Mol. Weight: 910.87 g/mol

Structure

SMILES: C1OC=CC(C1=C)CC(=O)OCCc2ccc(cc2)OC(=O)CC(C3=C)C=COC3OC4CCCCO4

Level: 3

Mol. Weight: 910.87 g/mol

Structure

SMILES: C1OC=CC(C1=C)CC(=O)OCCc2ccc(cc2)OC(=O)CC(C3=C)C=COC3

Level: 2

Mol. Weight: 910.87 g/mol

Structure

SMILES: c1ccccc1CCOC(=O)CC(C2=C)C=COC2OC3CCCCO3

Level: 2

Mol. Weight: 910.87 g/mol

Structure

SMILES: c1ccccc1OC(=O)CC(C2=C)C=COC2OC3CCCCO3

Level: 2

Mol. Weight: 910.87 g/mol

Structure

SMILES: C1OC=CC(C1=C)CC(=O)OCCc2ccccc2

Level: 1

Mol. Weight: 910.87 g/mol

Structure

SMILES: C1OC=CC(C1=C)CC(=O)Oc2ccccc2

Level: 1

Mol. Weight: 910.87 g/mol

Structure

SMILES: C1C=COC(C1=C)OC2CCCCO2

Level: 1

Mol. Weight: 910.87 g/mol

Structure

SMILES: C=C1CC=COC1

Level: 0

Mol. Weight: 910.87 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 910.87 g/mol

Structure

SMILES: c1ccccc1

Level: 0

Mol. Weight: 910.87 g/mol

Adipocyte differentiation-inhibitory
Antidiabetic
Antiobesity property

Absorption

Caco-2 (logPapp)
-6.17
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
1300.060
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
170670.66

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.600
Plasma Protein Binding
66.17
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
3.990
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-3967.770
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.770
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.060
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-309761227.570
Rat (Acute)
3.080
Rat (Chronic Oral)
6.130
Fathead Minnow
391016.670
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Toxic
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
34833534.630
Hydration Free Energy
-2.920
Log(D) at pH=7.4
-5.050
Log(P)
-0.39
Log S
-2.85
Log(Vapor Pressure)
-1146948.77
Melting Point
197.19
pKa Acid
-8277.26
pKa Basic
-43.0
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Serpin domain-containing protein H0ZQY2 H0ZQY2_TAEGU Taeniopygia guttata 3 0.8121
Serpin domain-containing protein H0ZQY2 H0ZQY2_TAEGU Taeniopygia guttata 3 0.8121
beta-glucosidase Q92AS9 Q92AS9_LISIN Listeria innocua serovar 6a 3 0.7782
beta-glucosidase Q92AS9 Q92AS9_LISIN Listeria innocua serovar 6a 3 0.7782
Putative b-glycan phosphorylase Q21MB1 Q21MB1_SACD2 Saccharophagus degradans 4 0.7146
Putative b-glycan phosphorylase Q21MB1 Q21MB1_SACD2 Saccharophagus degradans 4 0.7146

Download SDF